NEW YORK, Jan. 13 (GenomeWeb News) - Q-RNA, of New York City, said today it has validated its nucleic acid ligand technology for use in prion diseases, and plans to use it to develop a new kind of test for Bovine Spongiform Encephalopathy, or Mad Cow Disease.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.